Cargando…

Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential

A “super” bioactive antibacterial hydrogel, Icariin-β-CD-inclusion complex/Bacterial cellulose and an equally capable counterpart Icariin-Bacterial cellulose (ICBC) were successfully produced with excellent antioxidant properties. The highly porous hydrogels demonstrated very high fluid/liquid absor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mensah, Alfred, Chen, Yajun, Asinyo, Benjamin K., Howard, Ebenezer Kofi, Narh, Christopher, Huang, Jieyu, Wei, Qufu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913306/
https://www.ncbi.nlm.nih.gov/pubmed/33546254
http://dx.doi.org/10.3390/nano11020387
_version_ 1783656774603112448
author Mensah, Alfred
Chen, Yajun
Asinyo, Benjamin K.
Howard, Ebenezer Kofi
Narh, Christopher
Huang, Jieyu
Wei, Qufu
author_facet Mensah, Alfred
Chen, Yajun
Asinyo, Benjamin K.
Howard, Ebenezer Kofi
Narh, Christopher
Huang, Jieyu
Wei, Qufu
author_sort Mensah, Alfred
collection PubMed
description A “super” bioactive antibacterial hydrogel, Icariin-β-CD-inclusion complex/Bacterial cellulose and an equally capable counterpart Icariin-Bacterial cellulose (ICBC) were successfully produced with excellent antioxidant properties. The highly porous hydrogels demonstrated very high fluid/liquid absorption capability and were functionally active as Fourier Transform Infrared Spectrometer (FTIR) test confirmed the existence of abundant hydroxyls (-OH stretching), carboxylic acids (-CH(2)/C-O stretching), Alkyne/nitrile (C≡C/C≡N stretching with triple bonds) and phenol (C-H/N-O symmetric stretching) functional groups. Scanning electron microscope (SEM) and X-ray diffraction (XRD) tests confirmed a successful β-CD-inclusion complexation with Icariin with a great potential for sustained and controlled drug release. In vitro drug release test results indicated a systemic and controlled release of the drug (Icariin) from the internal cavities of the β-CD inclusion complex incorporated inside the BC matrix with high Icariin (drug) release rates. Impressive inactivation rates against Gram-negative bacteria Escherichia coli ATCC 8099 and gram-positive bacteria Staphylococcus aureus ATCC 6538; >99.19% and >98.89% respectively were recorded, as the materials proved to be non-toxic on L929 cells in the in vitro cytotoxicity test results. The materials with promising versatile multipurpose administration of Icariin for wound dressing (as wound dressers), can also be executed as implants for tissue regeneration, as well as face-mask for cosmetic purposes.
format Online
Article
Text
id pubmed-7913306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79133062021-02-28 Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential Mensah, Alfred Chen, Yajun Asinyo, Benjamin K. Howard, Ebenezer Kofi Narh, Christopher Huang, Jieyu Wei, Qufu Nanomaterials (Basel) Article A “super” bioactive antibacterial hydrogel, Icariin-β-CD-inclusion complex/Bacterial cellulose and an equally capable counterpart Icariin-Bacterial cellulose (ICBC) were successfully produced with excellent antioxidant properties. The highly porous hydrogels demonstrated very high fluid/liquid absorption capability and were functionally active as Fourier Transform Infrared Spectrometer (FTIR) test confirmed the existence of abundant hydroxyls (-OH stretching), carboxylic acids (-CH(2)/C-O stretching), Alkyne/nitrile (C≡C/C≡N stretching with triple bonds) and phenol (C-H/N-O symmetric stretching) functional groups. Scanning electron microscope (SEM) and X-ray diffraction (XRD) tests confirmed a successful β-CD-inclusion complexation with Icariin with a great potential for sustained and controlled drug release. In vitro drug release test results indicated a systemic and controlled release of the drug (Icariin) from the internal cavities of the β-CD inclusion complex incorporated inside the BC matrix with high Icariin (drug) release rates. Impressive inactivation rates against Gram-negative bacteria Escherichia coli ATCC 8099 and gram-positive bacteria Staphylococcus aureus ATCC 6538; >99.19% and >98.89% respectively were recorded, as the materials proved to be non-toxic on L929 cells in the in vitro cytotoxicity test results. The materials with promising versatile multipurpose administration of Icariin for wound dressing (as wound dressers), can also be executed as implants for tissue regeneration, as well as face-mask for cosmetic purposes. MDPI 2021-02-03 /pmc/articles/PMC7913306/ /pubmed/33546254 http://dx.doi.org/10.3390/nano11020387 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mensah, Alfred
Chen, Yajun
Asinyo, Benjamin K.
Howard, Ebenezer Kofi
Narh, Christopher
Huang, Jieyu
Wei, Qufu
Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential
title Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential
title_full Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential
title_fullStr Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential
title_full_unstemmed Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential
title_short Bioactive Icariin/β-CD-IC/Bacterial Cellulose with Enhanced Biomedical Potential
title_sort bioactive icariin/β-cd-ic/bacterial cellulose with enhanced biomedical potential
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913306/
https://www.ncbi.nlm.nih.gov/pubmed/33546254
http://dx.doi.org/10.3390/nano11020387
work_keys_str_mv AT mensahalfred bioactiveicariinbcdicbacterialcellulosewithenhancedbiomedicalpotential
AT chenyajun bioactiveicariinbcdicbacterialcellulosewithenhancedbiomedicalpotential
AT asinyobenjamink bioactiveicariinbcdicbacterialcellulosewithenhancedbiomedicalpotential
AT howardebenezerkofi bioactiveicariinbcdicbacterialcellulosewithenhancedbiomedicalpotential
AT narhchristopher bioactiveicariinbcdicbacterialcellulosewithenhancedbiomedicalpotential
AT huangjieyu bioactiveicariinbcdicbacterialcellulosewithenhancedbiomedicalpotential
AT weiqufu bioactiveicariinbcdicbacterialcellulosewithenhancedbiomedicalpotential